Search Results for: genetic testing

Genzyme Genetics, Cambridge, Mass, has signed a sublicense agreement with DxS Ltd, Manchester, UK in which it will grant DxS worldwide rights with the exception of North America and Hong Kong for diagnostic testing of epidermal growth factor receptor mutations in non-small cell lung cancer.

Genzyme Genetics, Cambridge, Mass, a nationwide provider of genetic testing and counseling services for physicians and patients, plans to participate in a multi-center Cancer and Leukemia Group B study that will include 1,700 newly diagnosed patients with chronic lymphocytic leukemia.